Marketplace interviewed Partner Greg Husisian about the Foreign Investment Risk Review Modernization Act for the story “Congress Weighs Changes to Foreign Investment Oversight.” The legislation is intended to give the Committee on Foreign Investment in the United States new powers and more funding as the United States government grapples with how to best limit Chinese investment in critical technologies such as semiconductors and mobile broadband. The legislation would build on existing export controls and cover other types of deals such as joint ventures.
“That’s the part I find most fascinating. They’re looking at other situations,” Husisian said. “By requiring a kind of licensing scheme, they can potentially slow down or block the transfer of very important economic and national security type of information.”
“That’s the part I find most fascinating. They’re looking at other situations,” Husisian said. “By requiring a kind of licensing scheme, they can potentially slow down or block the transfer of very important economic and national security type of information.”
People
Related News
26 March 2024
In the News
Foley Made ‘Great Strides’ in 2023 as Firm Sees Record Revenue and Profits
In the article, “Diversity of Practices Helped Foley Grow Revenue by 8.1%, Profits Per Equity Partner by 11.5%” The American Lawyer notes that strong demand across each of Foley’s major strategic sectors – including energy, health care and life sciences, innovative technology, and manufacturing – led to record growth.
22 March 2024
In the News
Foley LA Prepares Boys & Girls Clubs Students for Youth of the Year Competition
Foley & Lardner LLP partner Nicholas Gross and associates Trevor Mullin, Kathryn Petrosky, Jordan Smiley, Savannah Levin, Troy Tessem, and Tam Wheat helped prepare students from the Boys & Girls Clubs of Metro Los Angeles for the annual Youth of the Year competition.
22 March 2024
In the News
Kyle Faget Quoted on FDA’s Approach to AI in Digital Health
Foley & Lardner LLP partner Kyle Faget is quoted in the Modern Healthcare article, “FDA is digital health’s gatekeeper amid AI boom.”